Search results
20 maj 2021 · This review will discuss the role of key imaging modalities, correlate imaging signs across varied STGD1 presentations and illustrate the use of multimodal imaging as an outcome measure in determining the efficacy of emerging STGD1 specific therapies.
1 gru 2014 · Imaging Characteristics. Fluorescein angiography (FA), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT) can help diagnose and characterize Stargardt disease. The hallmark finding on imaging of Stargardt disease is a “dark choroid” on FA (Fig. 2).
6 mar 2023 · To explore fundus autofluorescence (FAF) imaging as an alternative to electroretinography as a noninvasive, quick, and readily interpretable method to predict disease progression in Stargardt disease (STGD).
8 sty 2024 · Objectives: Assess disease progression and visual function in Stargardt disease to tailor individualized treatment plans. Identify the genetics related to Stargardt disease and describe the various clinical features and differential diagnosis of this condition. Interpret the various imaging modalities used to diagnose and assess Stargardt disease.
Imaging Characteristics. Fluorescein angiography (FA), fundus autofluorescence (FAF), and spec tral-domain optical coherence tomography (SD-OCT) can help diagnose and characterize Stargardt disease.
Diagnostic evaluation of Stargardt disease is based on family history, visual acuity, fundus examination, visual field testing, fluorescein angiography, fundus autofluorescence (FAF), electroretinography (ERG) and optical-coherence tomography (OCT).
Imaging and disease progression. Imaging techniques providing enhanced assessment of retinal architecture have proven valuable in diagnosis, monitoring and probing the pathogenesis of STGD1, and include FAF, SD-OCT and adaptive optics scanning light ophthalmoscopy (AOSLO).
